U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Center for Instrumental Analysis of China Pharmaceutical University Center for Drug Evaluation and Research (CDER) CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Imperial Palace Commodity -Dongguan- Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
BioStem Life Sciences Center for Biologics Evaluation and Research (CBER) Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Fagron Compounding Services, LLC dba Fagron Sterile Service Center for Drug Evaluation and Research (CDER) Compounding Pharmacy/Adulterated Drug Products
Global Calcium Pvt. Limited Center for Drug Evaluation and Research (CDER) CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Shantou Kangjie Daily Chemical Industry Co., Ltd Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Talla Imports, LLC Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)
Mihon Corp. d/b/a VitalityVita and Boulla, LLC Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded
Chara Biologics, Inc. Center for Biologics Evaluation and Research (CBER) CGMP/Deviations/Biologics License Application (BLA)
Americo F. Padilla, M.D./Miami Dade Medical Research Institute Center for Drug Evaluation and Research (CDER) Clinical Investigator

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top